Amgen
North America, California, United States, Thousand Oaks
Description
Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
Investor Profile
Amgen has made 18 investments, with 0 in the past 12 months and 39% as lead.
Stage Focus
- Series B (17%)
- Corporate Round (17%)
- Post Ipo Equity (11%)
- Non Equity Assistance (11%)
- Series Unknown (11%)
- Series E (11%)
- Series C (6%)
- Grant (6%)
- Post Ipo Debt (6%)
- Series A (6%)
Country Focus
- United States (78%)
- Germany (11%)
- Israel (6%)
- United Kingdom (6%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Health Diagnostics
- Therapeutics
- Enterprise Software
- Medical Device
- Pharmaceutical
- Analytics
- Data Integration
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
